APA (7th ed.) Citation

Jacoby, M. A., Finn, L., Emadi, A., Saba, N. S., Powell, B. L., Seiter, K., . . . Male, H. J. (2021). Frequency of infusion-related reactions with CPX-351 treatment in an observational study in adults with newly diagnosed therapy-related AML or AML with myelodysplasia-related changes (AML-MRC). Leukemia & Lymphoma, 62(10), 2539. https://doi.org/10.1080/10428194.2021.1919668

Chicago Style (17th ed.) Citation

Jacoby, Meagan A., Laura Finn, Ashkan Emadi, Nakhle S. Saba, Bayard L. Powell, Karen Seiter, Rosella Garcia, Stefan Faderl, and Heather J. Male. "Frequency of Infusion-related Reactions with CPX-351 Treatment in an Observational Study in Adults with Newly Diagnosed Therapy-related AML or AML with Myelodysplasia-related Changes (AML-MRC)." Leukemia & Lymphoma 62, no. 10 (2021): 2539. https://doi.org/10.1080/10428194.2021.1919668.

MLA (9th ed.) Citation

Jacoby, Meagan A., et al. "Frequency of Infusion-related Reactions with CPX-351 Treatment in an Observational Study in Adults with Newly Diagnosed Therapy-related AML or AML with Myelodysplasia-related Changes (AML-MRC)." Leukemia & Lymphoma, vol. 62, no. 10, 2021, p. 2539, https://doi.org/10.1080/10428194.2021.1919668.